Gene Medicine | Prometheism.net – Transhuman Prometheans …

BALTIMORE, Md. via PRWEB Today Insilico Medicine, Inc., a Baltimore-based company using advances in genomics to discover new therapies to target aging and age-related diseases, announced the appointment .. Continue reading

Drugs used to block copper absorption for a rare genetic condition may find an additional use as a treatment for certain types of cancer, researchers at Duke Medicine report. The researchers found that cancers with a mutation in the BRAF gene require copper to promote tumor growth. These tumors include melanoma, the most dangerous form of skin cancer that kills an estimated 10,000 people in the United States a year, according to the National Cancer Institute. Continue reading

A new study shows that a gene discovered 30 years ago and now known to play a fundamental role in cancer development produces five different gene variants (called isoforms), rather than just the one original form, as thought. The study of the NRAS gene by researchers at The Ohio State University Comprehensive Cancer Center Arthur G Continue reading

Stanford University researcher Irving Weissman explains how the drug Rituxan, generically called rituximab, improves the cancer-killing effect of a new antibody that renders cancer cells vulnerable to immune attack. He spoke Monday, April 7, at the American Association for Cancer Research meeting in San Diego. Continue reading

PUBLIC RELEASE DATE: 6-Apr-2014 Contact: Carrie Strehlau carrie.strehau@stjude.org 901-595-2295 St. Jude Childrens Research Hospital (MEMPHIS, TENN Continue reading

DOWNINGTOWN, Pa., April 6, 2014 /PRNewswire-USNewswire/ The Friedreich's Ataxia Research Alliance (FARA) is pleased to recognize the ground-breaking gene-therapy research of FARA-funded scientist Dr. Continue reading

NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of the nCounter PanCancer Pathways Panel, a highly-multiplexed, digital gene expression assay that offers a unique way for translational researchers to investigate cancer biology across all major cancer pathways. Continue reading

PUBLIC RELEASE DATE: 4-Apr-2014 Contact: Allison Hydzik hydzikam@upmc.edu 412-559-2431 University of Pittsburgh Schools of the Health Sciences SAN DIEGO, April 4, 2014 An examination of the genetic landscape of head and neck cancers indicates that while metastatic and primary tumor cells share similar mutations, recurrent disease is associated with gene alterations that could be exquisitely sensitive to an existing cancer drug. Researchers from the University of Pittsburgh Cancer Institute (UPCI) and Yale University School of Medicine will share their findings during a mini-symposium Sunday at the American Association for Cancer Research Annual Meeting 2014. About 50 percent of patients diagnosed with head and neck squamous cell cancers already have disease that has spread, or metastasized, to the lymph nodes, explained Jennifer Grandis, M.D., distinguished professor and vice chair of research, Department of Otolaryngology, Pitt School of Medicine, and director of the Head and Neck Program at UPCI, partner with UPMC CancerCenter Continue reading

A multidisciplinary research team of scientists, clinicians and biostatisticians led by John Guy, M.D., professor of ophthalmology and director of the ocular gene therapy laboratory at the Bascom Palmer Eye Institute of the University of Miami Miller School of Medicine, has pioneered a gene therapy approach for Leber Hereditary Optic Neuropathy , an inherited genetic disorder that causes rapid Continue reading

Continue reading here:

Gene Medicine | Prometheism.net - Transhuman Prometheans ...